Detalhe da pesquisa
1.
Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate.
Prostate
; 84(2): 148-157, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849074
2.
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
Gut
; 71(5): 961-973, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849943
3.
SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma.
Mod Pathol
; 34(10): 1810-1819, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103668
4.
Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.
Mod Pathol
; 31(12): 1787-1800, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973652
5.
AI powered quantification of nuclear morphology in cancers enables prediction of genome instability and prognosis.
NPJ Precis Oncol
; 8(1): 134, 2024 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38898127
6.
Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate.
bioRxiv
; 2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066381
7.
ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors.
Cancers (Basel)
; 14(7)2022 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406561
8.
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.
Cell Rep
; 38(2): 110216, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021084
9.
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers.
Cell Oncol (Dordr)
; 43(5): 847-861, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468444
10.
Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.
Pathology
; 52(3): 336-347, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32111396
11.
Telomere alterations in neurofibromatosis type 1-associated solid tumors.
Acta Neuropathol Commun
; 7(1): 139, 2019 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462295
12.
Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.
Mol Cancer Res
; 17(12): 2480-2491, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611308
13.
Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.
Brain Pathol
; 29(1): 126-140, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30192422
14.
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.
Sci Transl Med
; 11(479)2019 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760578
15.
ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
PLoS One
; 13(9): e0204159, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30226859
16.
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.
Nat Commun
; 9(1): 2087, 2018 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29802247
17.
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
Cancer Res
; 77(2): 227-233, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062403
18.
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
Clin Cancer Res
; 23(6): 1598-1606, 2017 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27663587
19.
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.
Sci Transl Med
; 8(328): 328ra28, 2016 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26936505
20.
Genetic alterations associated with ALTered telomeres.
Oncotarget
; 9(73): 33739-33740, 2018 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333904